Overview of Obesity Treatment MarketThe global Obesity Treatment Market is valued at USD 22.2 Billion in 2024 and is projected to reach a value of USD 194.1 Billion by 2035 at a CAGR (Compound Annual ...

In 2022, over 1 billion people were affected by obesity, driving innovation in therapeutic advancements. Emerging treatments focus on appetite contro ...

Cipla Limited is planning to enter the weight management segment in India, announced the company’s MD and global CEO Umang ...

Mumbai: Mumbai-based pharma giant Cipla is gearing up to make an entry into India's rapidly growing weight management market, ...

The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...

Cipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and Danish firm Novo Nordisk.

Pharmaceutical giant Cipla plans to enter India's weight management sector, while also bolstering its central nervous system ...

Indian pharmaceutical giant, Cipla, is preparing to venture into the weight management sector in India, according to its MD and global CEO Umang Vohra.

Cipla expands into CNS and weight management segments, focusing on patient needs and innovation for long-term value.

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has ...

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...